Skip to content

Absci Corporation ABSI Other Income (Expense)

Other Income (Expense) at other companies

Schrodinger logo
SchrodingerSDGR
-$10.82M-21.7%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$6.4M+157%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-$23.36M-366%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$7.98M-17.5%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$18.21M-55.0%
ADMA Biologics logo
ADMA BiologicsADMA
-$1.15M+19.8%

Segments

By segment

See full
Segment One-$3K+78.6%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's other income (expense)?
Absci Corporation (ABSI) reported other income (expense) of $1.27M in Q1 2026.
How has Absci Corporation's other income (expense) changed year-over-year?
Absci Corporation's other income (expense) decreased by 8.3% year-over-year, from $1.38M to $1.27M.
What is the long-term trend for Absci Corporation's other income (expense)?
Over 4 years (2021 to 2025), Absci Corporation's other income (expense) has grown at a -37.7% compound annual growth rate (CAGR), from -$34.62M to $5.2M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.